Epirubicin and gemcitabine (EG) as first-line treatment in malignant pleural mesothelioma (MPM): An A.I.P.O. multicenter phase II trial
- Resource Type
- Academic Journal
- Source
- Annals of Oncology. Oct 01, 2002 13 Suppl 5:150-150
- Subject
- Language
- English
- ISSN
- 0923-7534